Technical Analysis for SELB - Selecta Biosciences, Inc.
|Grade||Last Price||% Change||Price Change|
SELB closed up 3.92 percent on Thursday, January 17, 2019, on 1.12 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
|See historical SELB trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 17||Boomer Sell Setup||Bearish Swing Setup||0.00%|
|Jan 17||Narrow Range Bar||Range Contraction||0.00%|
|Jan 17||NR7||Range Contraction||0.00%|
|Jan 17||Inside Day||Range Contraction||0.00%|
|Jan 17||Wide Bands||Range Expansion||0.00%|
|Jan 17||Oversold Stochastic||Weakness||0.00%|
|Jan 16||New 52 Week Closing Low||Bearish||3.92%|
|Jan 16||180 Bearish Setup||Bearish Swing Setup||3.92%|
|Jan 16||Inside Day||Range Contraction||3.92%|
|Jan 16||Wide Bands||Range Expansion||3.92%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Selecta Biosciences, Inc., a clinical-stage biotechnology company, develops targeted therapies that use immunomodulators encapsulated in nanoparticles to induce antigen-specific immune responses to prevent and treat disease. The company focus is on developing and commercializing differentiated therapies that are designed to modulate the immune system to effectively and safely treat rare diseases by mitigating the formation of anti-drug antibodies in response to life-sustaining biologic drugs. Its lead product candidate is SEL-212 for the treatment of refractory and chronic tophaceous gout. The company serves customers in the United States and internationally. Selecta Biosciences, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more SELB news...
|52 Week High||16.55|
|52 Week Low||1.97|
|200-Day Moving Average||10.4451|
|50-Day Moving Average||4.4682|
|20-Day Moving Average||2.7833|
|10-Day Moving Average||2.3685|
|Average True Range||0.4098|
|Chandelier Exit (Long, 3 ATRs )||3.4706|
|Chandelier Exit (Short, 3 ATRs )||3.1994|
|Upper Bollinger Band||3.9086|
|Lower Bollinger Band||1.658|
|Percent B (%b)||0.21|
|MACD Signal Line||-0.8518|
|Market Cap||46.8 Million|
|Num Shares||22.1 Million|
|Price-to-Earnings (P/E) Ratio||-0.74|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||2.29|
|Resistance 3 (R3)||2.27||2.21||2.26|
|Resistance 2 (R2)||2.21||2.16||2.21||2.25|
|Resistance 1 (R1)||2.16||2.14||2.19||2.18||2.24|
|Support 1 (S1)||2.05||2.05||2.08||2.07||2.00|
|Support 2 (S2)||1.99||2.03||1.99||1.99|
|Support 3 (S3)||1.94||1.99||1.98|
|Support 4 (S4)||1.96|